Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 13/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 12/20 | 0.34 |
| ▸ | MMP1 | P03956 | 2/20 | 0.34 |
| ▸ | MMP2 | P08253 | 2/20 | 0.34 |
| ▸ | MMP9 | P14780 | 2/20 | 0.34 |
| ▸ | MMP8 | P22894 | 2/20 | 0.34 |
| ▸ | MMP13 | P45452 | 2/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | F2 | P00734 | 1/20 | 0.31 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.31 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.31 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7141002 | 1.00 | THRB (0.59) | THRBCA2LMNACA1MMP1 | |
| SCHEMBL810923 | 1.00 | THRB (0.59) | THRBCA2LMNACA1MMP1 | |
| SCHEMBL811565 | 1.00 | THRB (0.59) | THRBCA2LMNACA1MMP1 | |
| SCHEMBL810833 | 1.00 | THRB (0.59) | THRBCA2LMNACA1MMP1 | |
| SCHEMBL28450248 | 1.00 | THRB (0.59) | THRBCA2LMNACA1MMP1 | |
| SCHEMBL159453 | 1.00 | THRB (0.59) | THRBCA2LMNACA1MMP1 | |
| SCHEMBL428765 | 1.00 | THRB (0.59) | THRBCA2LMNACA1MMP1 | |
| SCHEMBL10622506 | 1.00 | THRB (0.59) | THRBCA2LMNACA1MMP1 | |
| SCHEMBL810417 | 1.00 | THRB (0.59) | THRBCA2LMNACA1MMP1 | |
| SCHEMBL10617899 | 1.00 | THRB (0.59) | THRBCA2LMNACA1MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240166658-A1 | PORPHYRIN DERIVATIVES AND USES THEREOF | UNIVERSITY OF TASMANIA (AU) | 2024-05-23 | — | — | US | disclosed |
| EP-4298101-A1 | PORPHYRIN DERIVATIVES AND USES THEREOF | University Of Tasmania (AU) | 2024-01-03 | — | — | EP | disclosed |
| WO-2022178593-A1 | PORPHYRIN DERIVATIVES AND USES THEREOF | UNIVERSITY OF TASMANIA (AU) | 2022-09-01 | — | — | WO | disclosed |
| CN-113355017-B | Low-refractive-index optical fiber coating resin with high glass transition temperature | 武汉长盈鑫科技有限公司 | 2022-04-29 | — | — | CN | disclosed |
| CN-113355017-A | Low-refractive-index optical fiber coating resin with high glass transition temperature | 武汉长盈鑫科技有限公司 | 2021-09-07 | — | — | CN | disclosed |
| US-8436184-B2 | 6-(biphenyl-ester)-3H-naphtho[2,1-b]pyrans as photochromic dichroic dyes and optical article containing them | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE (FR) | 2013-05-07 | — | — | US | disclosed |
| US-20100039688-A1 | 6-(BIPHENYL-ESTER)-3H-NAPHTHO[2,1-B]PYRANS AS PHOTOCHROMIC DICHROIC DYES AND OPTICAL ARTICLE CONTAINING THEM | ESSILOR INTERNATIONAL (FR) | 2010-02-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100039688-A1 | 6-(BIPHENYL-ESTER)-3H-NAPHTHO[2,1-B]PYRANS AS PHOTOCHROMIC DICHROIC DYES AND OPTICAL ARTICLE CONTAINING THEM | NR0B1, CBR1, NR0B2 | THRB 723/4885CA2 982/4885LMNA 2174/4885 |
| US-20240166658-A1 | PORPHYRIN DERIVATIVES AND USES THEREOF | PFAS, PCBP1, FGR | THRB 889/4885CA2 2647/4885LMNA 4166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.